Evidence-based medicine: The dilemma of transplantation in patients with HIV infection

Current Opinion in Organ Transplantation

Volumn 9, Issue 4, 2004, Pages 422-427

  Coffman, Kathy L ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

HIV infected patients; Solid organ transplantation

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; AMPRENAVIR; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CYCLOSPORIN; CYTOCHROME P450 3A4; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; GUANOSINE DIPHOSPHATE; INDINAVIR; KETOCONAZOLE; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; METHADONE; MYCOPHENOLIC ACID; NELFINAVIR; PROTEINASE INHIBITOR; RAPAMYCIN; RIBAVIRIN; RITONAVIR; SAQUINAVIR; STAVUDINE; STEROID; TACROLIMUS; UNINDEXED DRUG; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLOIMMUNIZATION; ANTIVIRAL ACTIVITY; COMORBIDITY; CYTOPENIA; DISEASE COURSE; DRUG EFFICACY; DRUG REEXPOSURE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH INSURANCE; HEART TRANSPLANTATION; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; INFORMED CONSENT; INTRAVENOUS DRUG ABUSE; KIDNEY TRANSPLANTATION; LACTIC ACIDOSIS; LIVER FIBROSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; MASS SCREENING; MEDICAL ETHICS; MITOCHONDRIAL TOXICITY; MORTALITY; MYOGLOBINURIA; NEPHROTOXICITY; NEUROTOXICITY; ORGAN TRANSPLANTATION; PANCREATITIS; PREVALENCE; PRIVACY; REMISSION; REVIEW; RHABDOMYOLYSIS; STEATOSIS; SUPERINFECTION; SURVIVAL; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 16344388214     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mot.0000142726.14201.8a     Document Type: Review

References (53)

1. Delaney V, Sumrani N, Hong J, et al.: The course of HIV disease in renal allograft recipients. Transpl Int 1992, 5(suppl 1):S129-S132.
2. Roland ME, Lo B, Braff J, et al.: Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. Arch Intern Med 2003, 163:1773-1778.
3. Fishman JA: Transplantation for patients infected with human immunodeficiency virus: no longer experimental but not yet routine. J Infect Dis 2003, 188:1405-1411.
4. Fung J: Transplantation in HIV-positive patients? June 28, 2001. Available at: http://www.natap.org/2001/jul/transplantation070901.htm
5. James JS: AIDS research "spin-off"-ganciclovir CMV prevention after liver transplantation. AIDS Treat News 1995, Jul 21:6.
6. Roland ME, Adey D, Carlson LL, et al.: Kidney and liver transplantation in HIV-infected patients: case presentations and review. AIDS Patient Care STDS 2003, 17:501-507.
7. Ragni MV, Belle SH, Kyung Ah I, et al.: Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003, 188:1412-1420.
8. Calabrese LH, Albrecht M, Young J, et al.: Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med 2003, 348:2323-2328.
9. Bisleri G, Morgan JA, Deng MC, et al.: Should HIV-positive recipients undergo heart transplantation? J Thorac Cardiovasc Surg 2003, 126:1639-1640.
10. Abbott KC, Swanson SJ, Agodoa LY, et al.: Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004, 15:1633-1699.
11. Hochegger K, Mayer GJ, Rosenkranz AR: Is HIV infection a contraindication for kidney transplantation? Nephrol Dial Transplant 2003, 18:217-218.
12. Krishnan A, Zaia J, Forman SJ: Should HIV-positive patients with lymphoma be offered stem cell transplant? Bone Marrow Transplant 2003, 32:741-748.
13. Neff GW, Bonham A, Tzakis AG, et al.: Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003, 9:239-247.
14. Brau N: Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy. AIDS 2003, 17:2279-2290.
15. Williams CF, Klinzman D, Yamashita TE, et al.: Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004, 350:981-990.
16. Costigliola P, Tumietto F, Zagnoli A, et al.: Need for liver transplant in HIV-positive patients: first results of a specific survey in Italy, Project HOST. AIDS 2003, 17:2119-2121.
17. Antoniades C, Macdonald C, Knisely A, et al.: Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient. Liver Transpl 2004, 10:699-702.
18. Schonder KS, Shullo MA, Okusanya O: Tacrolimus and lopinavir/ritonavir interaction in liver transplantation. Ann Pharmacother 2003, 37:1793-1796.
19. Antonini M, Ettorre GM, Vennarecci G, et al.: Anti-retrovirals and immunosuppressive drug interactions in a HIV-positive patient after liver transplantation. Hepatogastroenterology 2004, 51:646-648.
20. Jain AK, Venkataramanan R, Fridell JA, et al.: Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patients: a case report. Liver Transpl 2002, 8:838-840.
21. Piscitelli SC, Gallicano KD: Interactions among drugs for HIV and opportunistic infections. N Engl J Med 2001, 344:984-986.
22. Izzedine H, Launay-Vacher V, Baumelou A, et al.: Antiretroviral and immunosuppressive drug-drug interactions: an update. Kidney Int 2004, 66:532-541.
23. Prachalias AA, Pozniak A, Taylor C, et al.: Liver transplantation in adults coinfected with HIV. Transplantation 2001, 72:1684-1688.
24. deVera ME, Eghtestad B, Jain A, et al.: Liver transplantation in patients coinfected with HIV and hepatitis C. Presented at the American Transplant Congress 2002, Washington, DC, April 25-May 1, 2002.
25. Rao TK: Human immunodeficiency virus infection in end-stage renal disease patients. Semin Dial 2003, 16:233-244.
26. Shahinian V, Rajaraman S, Borucki M, et al.: Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis 2000, 35:884-888.
27. Ross MJ, Klotman PE: HIV-associated nephropathy: as disease of ethnic disparity for blacks. AIDS 2004, 18:1089-1099.
28. No authors listed: Organ transplantation. Proj Inf Perspect 2001, 33:11-12.
29. Halpern SD, Ubel PA, Caplan AL: Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002, 347:284-287.
30. Lafeuillade A, Poggi C, Hittinger E, et al.: Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies. J Infect Dis 2003, 188:1426-1432.
31. Ruiz-Mateos E, Rubio A, Vallejo D, et al.: Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ cells in HIV-infected adults after highly active antiretroviral therapy (HAART). Clin Exp Immunol 2004, 136:501-506.
32. Kuo PC: Reconsideration of HIV as a contraindication to transplantation. Transplantation 2001, 71:1689.
33. Halkic N, Bally F, Gillet M: Organ transplantation in HIV-infected patients. N Engl J Med 2002, 347:1801-1802.
34. Sugawara Y, Ohkubo T, Makuuchi M, et al.: Living-donor liver transplantation in an HIV-positive patient with hemophilia. Transplantation 2002, 74:1655-1656.
35. Toso C, Berney T, Oberholzer J, et al.: Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient. Am J Transplant 2003, 3:631-633.
36. Feng S, Buell J, Cherikh WS, et al.: Organ donors with positive viral serology of malignancy: risk of disease transmission by transplantation. Transplantation 2002, 74:1657-1663.
37. Cattani P, Nanni G, Graffeo R, et al.: Pre-transplantation human herpes virus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients. Transplant Proc 2000, 32:526.
38. Martin JN, Ganem DE, Osmond DH, et al.: Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338:948.
39. Koralnilk IJ: New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004, 17:365-370.
40. Leith JG, Clark DA, Matthews TJ, et al.: Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses. AIDS Res Hum Retroviruses 2003, 19:957-965.
41. Groux H, Torpier G, Monte D, et al.: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992, 175:331.
42. Schwarz A, Offermann G, Keller F, et al.: The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation-data on four cases and review of the literature. Transplantation 1993, 55:95-103.
43. Kuo PC, Stock PG: Transplantation in the HIV positive patient. Am J Transplant 2001, 1:13-17.
44. Roland ME, Stock PG: Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003, 75:425-429.
45. Goldberg D, Johnston J, Cameron S, et al.: Risk of HIV transmission from patients to surgeons in the era of post exposure prophylaxis. J Hosp Infect 2000, 44:99-105.
46. Halevy A, Brody B: Acquired immunodeficiency syndrome and the Americans with Disabilities Act: a legal duty to treat. Am J Med 1994, 96:282-288.
47. No authors listed: Ethicists say yes to transplants for HIV-positive patients. AIDS Policy Law. 2002; 17:9.
48. No authors listed: Lambda fights transplant discrimination for HIV-positive man. AIDS Policy Law 2003, 18:2.
49. No authors listed: Kaiser reverses on transplant denial for HIV-positive patient. AIDS Policy Law 2003, 18:2.
50. Picozzi M: HIV in liver transplantation: legal medicine and bioethics aspects. Transplant Proc 2003, 35:1007-1009.
51. Soriano V, Puoti M, Sulkowski M, et al.: Care of patients with hepatitis C and HIV co-infection. AIDS 2004, 18:1-12.
52. Tolan DJM, Davies MH, Millson CE: Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N Engl J Med 2001, 345:1781.
53. Vogel M, Voigt E, Michaelis HC, et al.: Management of drug-to-drug interactions between cyclosporine A and protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients. Liver Transpl 2004, 10:939-944.